ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 95 filers reported holding ALX ONCOLOGY HLDGS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,005,027 | -70.4% | 664,829 | -26.3% | 0.06% | -72.5% |
| Q4 2022 | $10,165,540 | +17.8% | 902,000 | 0.0% | 0.20% | +17.6% |
| Q3 2022 | $8,632,000 | -64.1% | 902,000 | +105.0% | 0.17% | -47.4% |
| Q2 2021 | $24,056,000 | +262.5% | 439,950 | +388.8% | 0.32% | +229.6% |
| Q1 2021 | $6,637,000 | – | 90,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $163,929,000 | 36.34% |
| Logos Global Management LP | 3,011,352 | $50,892,000 | 6.60% |
| Vivo Capital, LLC | 4,220,048 | $71,319,000 | 4.91% |
| Samsara BioCapital, LLC | 262,786 | $4,441,000 | 1.12% |
| Cormorant Asset Management, LP | 712,079 | $12,034,000 | 0.92% |
| Pier Capital, LLC | 394,443 | $6,666,000 | 0.85% |
| Redmile Group, LLC | 772,397 | $13,054,000 | 0.41% |
| Artal Group S.A. | 500,000 | $8,450,000 | 0.35% |
| Nan Fung Group Holdings Ltd | 41,950 | $709,000 | 0.34% |
| Orbimed Advisors | 621,700 | $10,507,000 | 0.17% |